Epimedium brevicornum Maxim alleviates diabetes osteoporosis by regulating AGE-RAGE signaling pathway
Abstract Objectives Epimedium brevicornum Maxim (EP) has a history of utilization in Chinese traditional medicine for the treatment of bone diseases. However, the precise mechanism by which EP extract (EPE) operates in Diabetes osteoporosis (DOP) remains ambiguous. The study was aimed to explore the...
Saved in:
| Main Authors: | Shan Shan Lei, Yu Yan Wang, Xiao Wen Huang, Xu Ping Wang, Ming Gao, Bo Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s10020-025-01152-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research Progress on the osteogenic differentiation of ADSCs induced by epimedium in the prevention and treatment of osteoporosis
by: Hai-Quan LIU, et al.
Published: (2023-10-01) -
Six pairs of enantiomeric prenylated flavonoids with cytotoxic activities from Epimedium sagittatum Maxim
by: Shuang-Shuang Xie, et al.
Published: (2025-05-01) -
Epimedium sagittatum Maxim ameliorates adriamycin‐induced nephropathy by restraining inflammation and apoptosis via the PI3K/AKT signaling pathway
by: Ru Wang, et al.
Published: (2023-06-01) -
Anthracnose of Korean Epimedium Caused by Colletotrichum gloeosporioides
by: Wan-Gyu Kim, et al.
Published: (2024-12-01) -
Progress in the application of epimedium and its major bioactive components in the treatment of orthopedic diseases
by: Dan Tong, et al.
Published: (2025-08-01)